Process for the preparation of pyrazolopyrimidinones
    1.
    发明授权
    Process for the preparation of pyrazolopyrimidinones 失效
    吡唑并嘧啶酮的制备方法

    公开(公告)号:US06667398B2

    公开(公告)日:2003-12-23

    申请号:US09886269

    申请日:2001-06-21

    IPC分类号: C07D48704

    摘要: There is provided a process for the production a compound of general formula I: wherein A, R1, R2, R3 and R4 have meanings given in the description, which process comprises the reaction of a compound of formula II, wherein Rx is a group substitutable by an aminopyrazole, with a compound of general formula III

    摘要翻译: 提供了制备通式I化合物的方法:其中A,R 1,R 2,R 3和R 4具有说明书中给出的含义,该方法包括 式II化合物,其中R x是可被氨基吡唑取代的基团,与通式III的化合物

    STABLE HYDRATE OF A MUSCARINIC RECEPTOR ANTAGONIST
    5.
    发明申请
    STABLE HYDRATE OF A MUSCARINIC RECEPTOR ANTAGONIST 有权
    稳定的水肿受体拮抗剂

    公开(公告)号:US20080167367A1

    公开(公告)日:2008-07-10

    申请号:US12049660

    申请日:2008-03-17

    IPC分类号: A61K31/40

    CPC分类号: C07D405/06

    摘要: A stable solid hydrate of a muscarinic receptor antagonist is useful in the treatment of irritable bowel syndrome, diverticular disease, oesophageal achalasia, chronic obstructive airways disease, over active bladder (including symptoms of incontinence, urge and frequency), urinary incontinence, neurogenic urinary urgency or pollakiuria, treatment of bladder functional disorder, urinary leakage, painful or difficult urination caused by neurogenic bladder, spastic or hypertonic bladder, dysfunctional bladder syndrome, gastrointestinal disorders including gastrointestinal hyperactivity, and relaxing effect on intestinal smooth muscle cells.

    摘要翻译: 毒蕈碱受体拮抗剂的稳定的固体水合物可用于治疗肠易激综合征,憩室疾病,食管贲门失弛缓症,慢性阻塞性气道疾病,活动性膀胱(包括失禁症状,呼吸和频率),尿失禁,神经源性尿急 或尿频,治疗膀胱功能障碍,尿漏,由神经源性膀胱,痉挛型或高渗性膀胱引起的疼痛或难排尿,功能障碍性膀胱综合征,胃肠道疾病,包括胃肠道多动症,以及对肠平滑肌细胞的松弛作用。

    Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof
    6.
    发明授权
    Process for preparation of pyrazolo[4,3-d]pyrimidin-7-ones and intermediates thereof 失效
    吡唑并[4,3-d]嘧啶-7-酮的制备方法及其中间体

    公开(公告)号:US06207829B1

    公开(公告)日:2001-03-27

    申请号:US09415440

    申请日:1999-10-08

    IPC分类号: C07D21300

    CPC分类号: C07D295/26 C07D487/04

    摘要: A process is provided for the preparation of a compound of formulae (IA) (sidenafil) and (IB) comprising reacting a compound of formula (IIA) and (IIB) respectively in the presence of —OR, wherein R in the case of formation of compound (IA) is CH2CH3 and R in the case of formation of compound (IB) is CH2CH2CH3, where X is a leaving group:

    摘要翻译: 提供了制备式(IA)(西多那非)和(IB)化合物的方法,包括分别在-OR存在下使式(IIA)和(IIB)化合物反应,其中在形成 化合物(IA)为CH 2 CH 3,在形成化合物(IB)的情况下,R为CH 2 CH 2 CH 3,其中X为离去基团: